Jesse Shefferman - Jan 3, 2023 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Mary Grendell Attorney-In-Fact
Stock symbol
TARA
Transactions as of
Jan 3, 2023
Transactions value $
-$18,491
Form type
4
Date filed
1/4/2023, 03:25 PM
Previous filing
Feb 10, 2023
Next filing
Jan 11, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability -$18.5K -6.6K -0.75% $2.80 873K Jan 3, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022.

Remarks:

Exhibit 24.1 - Power of Attorney